P

Purdue Canada, Valeant, Mylan

Multiple class actions related to opioid use are ongoing in Canada, with a $29.3 million settlement approved against Purdue Canada, Valeant, and Mylan.

Opening soonBritish Columbia, OntarioClaim deadline: Pending court decisionEstimated payout: Compensation pendingClaims not open yet

About this settlement

Class actions alleging harm from the overprescription of opioid medications and seeking recovery of healthcare costs.

Class actions concerning opioid use are continuing across Canada. In Ontario, a $29.3 million settlement was approved against Purdue Canada, Valeant, and Mylan in the case Gebien v Apotex Inc. The court found the settlement reasonable and approved a distribution protocol designed to provide accessible claims while prioritizing those most affected. In British Columbia, the Court of Appeal upheld the certification of a class action brought by the province against pharmaceutical manufacturers, wholesalers, and distributors to recover healthcare costs related to opioid overprescription.

Who qualifies

  • Individuals and Canadian governments affected by opioid use and overprescription.
  • Exact eligibility will be determined once the claim process opens.

Compensation pending

Claim deadline: Pending court decision

Related settlements

Estée Lauder logo

Estée Lauder

No proof required

Up to $5,000

Claims opening soon

Audible logo

Audible

No proof required

Compensation pending

Claims opening soon

Government of Canada logo

Government of Canada

Proof required

Up to $200,000

613 days left

Meta (Facebook) logo

Meta (Facebook)

No proof required

Up to $90

Claims opening soon

Ticketmaster logo

Ticketmaster

No proof required

Compensation pending

Claims opening soon

Apple logo

Apple

No proof required

Up to $100

Claims opening soon